Quotes 5-day view Delayed London Stock Exchange
01/18/2021
01/19/2021
01/20/2021
01/21/2021
01/22/2021
Date
381.5(c)
383(c)
397(c)
392(c)
389.5(c)
Last
79 082
109 436
214 915
178 129
194 938
Volume
0.00%
+0.39%
+3.66%
-1.26%
-0.64%
Change
Sales 2020
14,2 M
-
-
Net income 2020
94,3 M
-
-
Net Debt 2020
3,05 M
-
-
P/E ratio 2020
43,6x
Yield 2020
-
Sales 2021
11,1 M
-
-
Net income 2021
-124 M
-
-
Net cash position 2021
76,6 M
-
-
P/E ratio 2021
-3,19x
Yield 2021
-
Capitalization
1 523 M
1 521 M
-
EV / Sales 2020
108x
EV / Sales 2021
130x
Nbr of Employees
300
Free-Float
84,2%
PureTech Health PLC is a clinical stage biotechnology company. The Company is engaged in discovering, developing and commercializing medicines for diseases, including intractable cancers, lymphatic and gastrointestinal diseases, central nervous system disorders, and inflammatory and immunological diseases, among others. Its segments include Internal and Affiliates. The Internal division is focused on advancing a...
Notations Surperformance© of PureTech Health plc
Trading Rating :
Investor Rating :
All news about PURETECH HEALTH PLC
News in other languages on PURETECH HEALTH PLC
Analyst Recommendations on PURETECH HEALTH PLC
Chart PURETECH HEALTH PLC
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends PURETECH HEALTH PLC
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
3
Average target price
6,33 $
Last Close Price
5,33 $
Spread / Highest target
20,0%
Spread / Average Target
18,8%
Spread / Lowest Target
17,9%
Please enable JavaScript in your browser's settings to use dynamic charts.